South Africa accuses big pharmaceutical companies of plotting "evil plots"

- the leaked documents show that large pharmaceutical companies oppose the patent law amendment movement source: China Council for the promotion of drugs 2014-01-21 the pharmaceutical industry was accused of many illegal acts, but not often accused of "Satan plot" that would lead to "ethnic extinction" It was Aaron Motsoaledi, South Africa's health minister, who slammed large pharmaceutical companies in Friday's report for funding a public relations campaign aimed at opposing the favorable generic terms of the new patent law According to documents leaked by Reuters, ipasa is considering providing us $600000 organization to oppose the new patent law to tighten the country's "evergreen" provision of patents for minor changes in drugs Ipasa members include Sanofi, Baite international, Pfizer and Novartis The South African government wants more generic drugs on the market to reduce national health care costs These changes also benefit domestic pharmaceutical companies such as Aspen pharmaceuticals and Adcock Ingram Health care advocates in South Africa claim that so far the government has not even scrutinized patent applications This has resulted in many patents for the same drug, and hindered the development of the generic industry in the direction of making more affordable drugs Reuters reported that the event, planned by the US public affairs consulting company, recommended that ipasa strive to postpone the determination of the new patent law until after the general election in May The plan is to persuade lawmakers to vote for a change in patent law with serious political consequences Val Beaumont, a spokeswoman for ipasa, admitted to the press that the document was authentic, but it was just a proposal that ipasa had not yet approved "This proposal has not been accepted or implemented," she told Reuters As other countries strive to reduce medical costs, large pharmaceutical companies have been fighting intellectual property around the world, especially in India and China China, for example, last year cancelled a patent on Gilead Sciences' HIV and hepatitis B drug, Viread (tenofovir), when a generic company challenged it The move is expected to halve the price of the drug Such moves have scared pharmaceutical companies of patent law changes South Africa is a small market, but it is one of the emerging markets that pharmaceutical companies are turning to after the slowdown in developed countries Now that the document has been released, Reuters pointed out that the industry association is likely to terminate the plan Motsoaledi confessed his thoughts on the sport "This document will sentence many South Africans to death," he said It's a genocide plan " Original link: http:// UTM \ \